| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/08/2003 | US6545037 Thromboxane A2 (TXA2) receptor and 5HT2 serotonergic receptor antagonists; 3-(6-(((4-chlorophenyl)sulphonyl)amino)-3-((2-(4-methyl-1 -piperazinyl)phenoxy)methyl)-5,6, 7,8-tetrahydro-1-naphthyl)propanoic acid for example |
| 04/08/2003 | US6545027 Methods of modulating NF-kB transcription factor |
| 04/08/2003 | US6545026 Increase the transactivation of receptor as a ligand of human peroxisome proliferator-activated receptor and exhibit blood glucose-decreasing action and lipid-decreasing action |
| 04/08/2003 | US6545025 Antiinflammatroy agents; antiallergens |
| 04/08/2003 | US6545023 For treating rheumatoid arthritis; for examle, 1-(4-(4-fluorophenyl)piperidin-1-yl),3-(2-methoxy-4 -chlorobenzylaminocarbonyl),3-isopropyl-cyclopentane |
| 04/08/2003 | US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders |
| 04/08/2003 | US6545020 Farnesyl Protein transferase inhibitors with in vivo radiosensitizing properties |
| 04/08/2003 | US6545018 Oxamic acids and derivatives as thyroid receptor ligands |
| 04/08/2003 | US6545013 2,7-naphthyridine derivatives |
| 04/08/2003 | US6545004 Treating cellular proliferative diseases and disorders associated with KSP kinesin activity. |
| 04/08/2003 | US6545002 Treating asthma, diarrhea, insulin resistance, diabetes, ischemia/reprefusion injuries, diabetic retinopathy or hyperbaric oxygen-induced retinopathy |
| 04/08/2003 | US6544993 Tetrahydrothiopyranphthalazinone derivatives as PDE4 inhibitors |
| 04/08/2003 | US6544992 Carbonylamino pyrrolidine and piperidine derivatives |
| 04/08/2003 | US6544990 Such as N-(4-chlorobenzyl)-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide for treatment against herpes viruse; enzyme inhibitors |
| 04/08/2003 | US6544988 Tyrosine kinase inhibitors |
| 04/08/2003 | US6544987 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 04/08/2003 | US6544985 For therapy of acute and/or chronic neurological disorders such as psychosis, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficits |
| 04/08/2003 | US6544981 Anticoagulants, cardiovascular disorders |
| 04/08/2003 | US6544979 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents |
| 04/08/2003 | US6544977 Crystalline forms of 1s-[1-alpha(2s*,3r*), 9alpha]6, 10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9[[(1-isoquinolyl)carbonyl]amino]octahydro-6h-pyridazino [1,2-a] [1,2] diazepin-1-carboxamide |
| 04/08/2003 | US6544971 Alarm device especially for detecting fires, unauthorized entry or sleep apnea, or the presence of CO, CH4, propane or radon |
| 04/08/2003 | US6544964 Cyclodextrin derivatives in which at least one of the hydroxy groups has been methylated whilst the other hydroxy groups may be modified by methyl groups or other groups, for complexing lead ions. |
| 04/08/2003 | US6544963 Alkali metal or alkali earth metal salt of carboxylmethyl cellulose, and a carrier; promoting cellular adhesion, wound healing, controlling bleeding |
| 04/08/2003 | US6544960 Chemical compounds |
| 04/08/2003 | US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation |
| 04/08/2003 | US6544787 Non-myeloablative/lymphoablative conditioning regimen to induce patient anti-donor unresponsiveness in stem cell transplantation |
| 04/08/2003 | US6544740 Measuring protease; calibration; insertion of enbryos |
| 04/08/2003 | US6544561 Neutral to mildly alkaline; preventing and/or treating certain inflammatory diseases and/or degenerative diseases and/or certain viral diseases in a mammal |
| 04/08/2003 | US6544556 Prevents gastrointestinal side effects |
| 04/08/2003 | US6544551 Solid pharmaceutical compositions containing hexedecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis |
| 04/08/2003 | US6544550 Medicaments for gastrointestinal disorders |
| 04/08/2003 | US6544547 Nutritional composition containing methionine |
| 04/08/2003 | US6544545 Providing needle-less device comprising a barrel member and a plunger, contacting first end of the barrel member to the patient's skin; depressing the plunger, thereby forcing medicament through the skin, to thereby administer medicament |
| 04/08/2003 | US6544523 Mutant forms of Fas ligand and uses thereof |
| 04/08/2003 | US6544518 Vaccines |
| 04/08/2003 | CA2275323C Asymmetric synthesis of benzoxazinones |
| 04/08/2003 | CA2254152C New metalloprotease inhibitors, their preparation process and the pharmaceutical compositions which use them |
| 04/08/2003 | CA2184584C Vascular endothelial growth factor 2 |
| 04/08/2003 | CA2163524C Assay and reagents for identifying anti-proliferative agents |
| 04/08/2003 | CA2123548C Piperazine derivatives |
| 04/08/2003 | CA2120736C Collagen constructs |
| 04/08/2003 | CA2103829C Peg-interferon conjugates |
| 04/08/2003 | CA2084431C 17-spirofuran-3'-ylidene steroids |
| 04/08/2003 | CA2062271C Derivatives of substituted imidazol-2-one and process for their preparation |
| 04/08/2003 | CA2061907C Treatment of ocular hypertension with a synergistic combination |
| 04/08/2003 | CA2061601C Methods and compositions for the treatment of infection and control of flora |
| 04/08/2003 | CA2053216C Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 04/08/2003 | CA2050300C Tnf-inhibiting proteins and the preparation thereof |
| 04/08/2003 | CA2049212C 6-substituted-tetrahydrobenz ¬cd| indoles |
| 04/07/2003 | WO2002032866A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 04/04/2003 | WO2002030940A2 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
| 04/04/2003 | WO2002030390A2 Method for producing powdery formulations |
| 04/04/2003 | CA2424926A1 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
| 04/03/2003 | WO2003027927A1 Dna providing system |
| 04/03/2003 | WO2003027672A1 Novel screening method using prokineticin receptor |
| 04/03/2003 | WO2003027637A2 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior |
| 04/03/2003 | WO2003027632A2 Use of isogenic human cancer cells for high-throughput screening and drug discovery |
| 04/03/2003 | WO2003027282A1 Adamts-15, -16, -17, -18 and -19 |
| 04/03/2003 | WO2003027275A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 04/03/2003 | WO2003027266A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | WO2003027263A2 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | WO2003027246A2 Antagonists |
| 04/03/2003 | WO2003027234A2 Small organic molecule regulators of cell proliferation |
| 04/03/2003 | WO2003027154A1 Polymers with structure-defined functions |
| 04/03/2003 | WO2003027128A1 Chemical compounds |
| 04/03/2003 | WO2003027116A2 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives |
| 04/03/2003 | WO2003027113A1 1,6-naphthyridine derivatives as antidiabetics |
| 04/03/2003 | WO2003027112A1 1, 8-naphthyridine derivatives as antidiabetics |
| 04/03/2003 | WO2003027107A1 Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027105A1 Substituted 3-pyridyl thiophenes as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 04/03/2003 | WO2003027101A1 Substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027100A1 Substituted 3-pyridyl pyrimidines as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027098A1 Benzimidazole compound, process for producing the same, and use thereof |
| 04/03/2003 | WO2003027096A1 Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027095A1 Substituted 3-pyridyl tetrazoles as steroid c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027094A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027093A1 Chemical compounds |
| 04/03/2003 | WO2003027091A1 Pyrane derivatives as both ace- and nep- inhibitors |
| 04/03/2003 | WO2003027085A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027080A1 3-substituted-4-pyrimidone derivatives |
| 04/03/2003 | WO2003027077A1 Water-soluble phenylpyridazine derivatives and drugs containing the same |
| 04/03/2003 | WO2003027076A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 04/03/2003 | WO2003027075A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 04/03/2003 | WO2003027069A1 Preparation and use of pyrrole derivatives for treating obesity |
| 04/03/2003 | WO2003027068A2 Substituted amines for the treatment of neurological disorders |
| 04/03/2003 | WO2003027061A2 Muscarinic agonists |
| 04/03/2003 | WO2003027058A1 Sphingolipids |
| 04/03/2003 | WO2003026696A1 Method of controlling proliferation of cancer cells and cell death |
| 04/03/2003 | WO2003026689A1 Autologous growth factor cocktail composition, method of production and use |
| 04/03/2003 | WO2003026676A1 Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder |
| 04/03/2003 | WO2003026673A1 Modulation of vitamin storage |
| 04/03/2003 | WO2003026672A1 A method of reducing the in vivo cholesterol ester transfer protein mediated transfer of cholesteryl esters between high density lipoproteins (hdl) and low density lipoproteins (ldl) |
| 04/03/2003 | WO2003026671A1 Method of treating middle ear infections |
| 04/03/2003 | WO2003026669A1 Monobactam antibacterial compounds and methods of use thereof |
| 04/03/2003 | WO2003026662A1 Solid-state forms of n-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl)pyrazole |
| 04/03/2003 | WO2003026648A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| 04/03/2003 | WO2003026644A1 Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) |
| 04/03/2003 | WO2003026638A1 Neuroprotective treatment methods using selective inos inhibitors |
| 04/03/2003 | WO2003026634A1 Amines with antialcoholic agents |